CGTX - Balance Sheet - Cognition Therapeutics, Inc.

Current Liabilities	11.1 M
Accounts Payable	1.98 M
Short-Term Debt	193 K
Other Current Liabilities	8.96 M
Non-Current Liabilities	342 K
Long-Term Debt	342 K
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	25.0	29.9	41.6	54.7	5.2	2.9
Short Term Investments	0	0	0	0	0	0
Receivables	2.7	1.3	3.7	2.3	1.2	4.1
Inventory	0	0	0	2.0	0.5	0.1
Other Current Assets	1.9	3.0	2.4	2.0	0.6	0.1
Total Current Assets	29.6	34.2	47.6	59.0	6.9	7.2
PP&E	0.7	0.9	1.0	0.1	0.2	0.3
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0	0	1.7	0	0	0
Other Assets	0	0	0	0	0	0
Total Assets	30.2	35.2	50.4	59.1	7.1	7.5
LIABILITIES
Accounts Payable	2.0	3.7	3.2	4.2	2.0	2.4
Short Term Debt	0.2	0.7	0.3	0	0	4 K
Other Current Liabilities	7.9	4.1	2.6	3.7	1.2	1.3
Total Current Liabilities	11.1	10.2	7.8	7.9	3.2	3.7
Long Term Debt	0.3	0.5	1.4	0	12.9	6.9
Deferred Tax Income	0	0	(0.7)	0	0	0
Other Liabilities	0	0	(0.7)	0	59.2	55.3
Total Liabilities	11.5	10.7	10.2	7.9	75.3	65.9
EQUITY
Common Stock	60 K	32 K	29 K	22 K	1 K	1 K
Retained Earnings	(175.2)	(141.2)	(115.4)	(94.0)	(68.2)	(58.2)
Other Accumulative Comprehensive Income/Loss	0	(0.2)	(0.2)	(0.2)	(0.2)	(0.2)
Total Equity	18.8	24.5	40.2	51.3	(68.2)	(58.4)
Total Liabilities and Equity	30.2	35.2	50.4	59.1	7.1	7.5
SHARES OUTSTANDING
Common Shares Outstanding	39.7	30.0	29.0	22.2	21.9	21.9

Free